Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Journal of Immunology|April 29, 2004
Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitusDan M Waid, Gisela M Vaitaitis, David H Wagner
European Journal of Immunology|November 23, 2011
CD40 engagement of CD4+ CD40+ T cells in a neo-self antigen disease model ablates CTLA-4 expression and indirectly impacts toleranceJessica Carter, Gisela M Vaitaitis, Dan M Waid, et al.
Journal of Leukocyte Biology|May 13, 2008
Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetesDan M Waid, Gisela M Vaitaitis, Nathan D Pennock, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2013
An alternative role for Foxp3 as an effector T cell regulator controlled through CD40Gisela M Vaitaitis, Jessica R Carter, Dan M Waid, et al.
Diabetologia|August 9, 2014
A CD40-targeted peptide controls and reverses type 1 diabetes in NOD miceGisela M Vaitaitis, Michael H Olmstead, Dan M Waid, et al.
Journal of Neuroimmunology|April 3, 2014
Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cellsDan M Waid, Teri Schreiner, Gisela Vaitaitis, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2019
Biomarker Discovery in Pre-Type 1 Diabetes; Th40 Cells as a Predictive Risk FactorGisela M Vaitaitis, Marynette Rihanek, Aimon K Alkanani, et al.
Frontiers in Immunology|March 12, 2026
A CD40-targeting peptide, OPT501, modulates inflammation in canine diabetes mellitus improving clinical outcomesGisela M Vaitaitis, Dan M Waid, Christina Sharkey, et al.
Pageof 2